AI Contract Review for Medical Device Manufacturing Industry

Backed by Microsoft For Startups
Guided by Grayver Law Group
AES-256 Encryption
Personal (PII) & Corporate Data Redacted Before AI
Free during early access

Medical device contract review ensures manufacturers comply with FDA Quality System Regulation (21 CFR Part 820) across their entire supply chain. Justee AI analyzes supplier agreements, contract manufacturing arrangements, and design control contracts to ensure QSR compliance and proper risk allocation.

Free and no sign-up required.

Get Your Free Document Review

Federal only

Your data is protected at every layer

No file selected

Protected by reCAPTCHA. Privacy · Terms

Guest uploads are automatically deleted within 24 hours

Key Takeaways

Review supplier quality agreements for FDA 21 CFR Part 820 and ISO 13485 compliance

Verify design transfer agreements properly allocate development and validation responsibilities

Ensure contract manufacturer agreements include device history record and traceability requirements

Identify gaps in supplier control provisions that could impact FDA inspections and device recalls

1-2 minutes*

Average Review Time

58+ FDA QSR and ISO 13485 checks*

Compliance Checks

SOC 2 Type II, HIPAA compliant

Document Security

* Estimates based on typical documents. Actual results vary by document type and complexity.

FDA Quality System Regulation (21 CFR Part 820) requires medical device manufacturers to establish and maintain quality systems throughout the product lifecycle, including rigorous supplier and contract manufacturer controls. Under QSR Section 820.50, manufacturers must evaluate and select suppliers based on their ability to meet specified requirements, including quality requirements. FDA issues approximately 1,200 medical device warning letters annually, with supplier control deficiencies cited in 38% of cases. Contract manufacturing arrangements must specify device master record controls, design history file maintenance, complaint handling procedures, and corrective action protocols. The medical device recall rate increased 97% from 2015 to 2025, with third-party manufacturing cited as a contributing factor in 42% of Class I recalls. Contracts lacking detailed QSR compliance provisions expose manufacturers to regulatory enforcement and product liability exceeding $50 million per recall event.

Key Industry Regulations

FDA 21 CFR Part 820 - Quality System Regulation for Medical Devices

ISO 13485 - Medical Devices Quality Management Systems

FDA 21 CFR Part 803 - Medical Device Reporting (MDR)

FDA 21 CFR Part 820.50 - Purchasing Controls

ISO 14971 - Application of Risk Management to Medical Devices

EU Medical Device Regulation (MDR) 2017/745

FDA Design Control Guidance

How It Works

1
Upload Your Contract

Upload your contract in PDF, DOCX, or TXT format

2
AI Analysis

Our AI reviews for industry-specific compliance issues

3
Review Findings

Get detailed findings with regulatory citations

4
Take Action

Use our suggestions to improve compliance

What We Check

FDA QSR compliance verification - ensures supplier agreements align with 21 CFR Part 820 requirements

Design control validation - confirms design transfer contracts specify DHF, DMR, and validation responsibilities

Supplier control assessment - validates evaluation, selection, and ongoing monitoring provisions meet QSR standards

Traceability requirements - ensures contracts mandate lot tracking and device history record maintenance

CAPA and complaint handling - verifies agreements define corrective action and adverse event reporting obligations

Common Risks We Identify

Missing supplier evaluation criteria under QSR 820.50 exposing manufacturers to FDA observations during audits

Inadequate design transfer provisions failing to specify DHF ownership and design validation responsibilities

Ambiguous device history record requirements preventing effective traceability during recalls or field actions

Weak complaint handling procedures violating QSR 820.198 and delaying adverse event reporting to FDA

Insufficient CAPA provisions allowing repetitive manufacturing defects without systematic root cause analysis

Common Industry Documents

Supplier Quality Agreement

Defines component specifications, evaluation criteria, and ongoing monitoring requirements

Contract Manufacturing Agreement

Governs outsourced device production with QSR compliance terms

Design Transfer Agreement

Specifies design control responsibilities, DHF ownership, and validation requirements

Quality Agreement

Establishes QMS requirements and regulatory compliance obligations

Master Services Agreement

Framework for ongoing medical device manufacturing and testing services

Hypothetical Case Study by Justee

Justee recently analyzed a supplier quality agreement with a critical component supplier in Asia for a Class III medical device manufacturer in Minnesota producing implantable cardiac devices.

Issue Found: The agreement lacked specific supplier evaluation criteria required under QSR 820.50, did not define lot traceability requirements for device history records, and contained vague language about complaint handling that did not align with MDR reporting timelines

Justee Recommendation: We revised the agreement to include detailed supplier evaluation criteria with annual audits, mandatory lot-level traceability with certificates of conformance, 24-hour complaint notification requirements, and specific MDR reporting obligations aligned with 21 CFR Part 803, ensuring full QSR compliance and protecting against regulatory observations

Inadequate Supplier Control Provision

Problematic Language

"Supplier agrees to provide components that meet applicable quality standards and industry requirements. Supplier will maintain adequate quality control procedures."

Recommended Language

"Supplier shall provide components in strict accordance with specifications in Exhibit A and maintain a quality management system compliant with ISO 13485 and FDA 21 CFR Part 820. Customer shall evaluate and approve Supplier pursuant to QSR 820.50 based on documented quality system assessment. Supplier shall: (a) provide Certificate of Conformance for each lot confirming specification compliance, (b) maintain lot traceability enabling device history record correlation, (c) notify Customer within 24 hours of any non-conformances or complaints, (d) participate in Customer CAPA investigations, and (e) permit Customer and FDA audit access to facilities and quality records."

Why it matters: The original language fails to meet FDA QSR requirements. Section 820.50 mandates that manufacturers evaluate and select suppliers based on their ability to meet specified requirements including quality requirements. Without defined specifications, traceability requirements, and audit rights, the manufacturer cannot demonstrate adequate supplier control during FDA inspections. The revised language creates enforceable QSR-compliant obligations with traceability mechanisms essential for recalls and device history records.

No credit card required

"Justee is redefining the legal document compliance process across all practice areas, transforming hours of work into minutes, while reducing stress and boosting accuracy."

Artem Dolukhanyan
Artem Dolukhanyan

Partner, Corporate Transactions at Grayver Law Group

AI Review vs. Manual Review

FeatureJustee AI ReviewManual Review
Review Time1-2 minutes*2-4 hours
CostFree trial available$300-800+
Regulatory Coverage58+ FDA QSR and ISO 13485 checks*Varies by reviewer
Clause SuggestionsIncludedExtra fee
Availability24/7 instantBusiness hours
* Comparison data represents estimates based on industry research and internal testing for typical contract types. Review times, costs, and accuracy percentages vary by document complexity, length, jurisdiction, and specific legal requirements. See full disclaimer below.

Official Regulatory Resources

FDA Quality System Regulation (21 CFR 820)

Complete FDA Quality System Regulation for medical devices

ISO 13485 Medical Devices QMS

International standard for medical device quality management systems

FDA Design Control Guidance

FDA guidance on design controls and quality system requirements for medical devices

Important Legal Disclaimer

Not Legal Advice: The information and analysis provided by Justee AI is for general informational purposes only and does not constitute legal advice. While we strive to provide accurate and helpful information, our AI-powered service is not a substitute for professional legal counsel.

No Attorney-Client Relationship: Use of Justee AI does not create an attorney-client relationship. Communications with our service are not privileged or confidential in the legal sense.

Consult a Professional: For specific legal matters, we strongly recommend consulting with a qualified attorney licensed in your jurisdiction. Legal requirements vary by location and circumstances, and only a licensed attorney can provide advice tailored to your specific situation.

Performance Estimates (*): All statistics, metrics, and numerical claims on this page — including review times, cost comparisons, accuracy percentages, and database size — are estimates based on internal testing, industry research, and typical use cases. Actual results vary based on document type, complexity, length, jurisdiction, and other factors. Cost comparisons reference publicly available average attorney rates and are not guaranteed savings. "1M+ laws and regulations" refers to the breadth of Justee's reference database and does not imply that every provision is checked against every law for every document.

By using our service, you acknowledge that you have read and agree to our Terms of Use and understand the limitations of AI-powered legal analysis. You are solely responsible for verifying the accuracy and applicability of any information to your situation.

Frequently Asked Questions

QSR Section 820.50 requires manufacturers to establish and maintain procedures to ensure purchased or received product conforms to specified requirements. Supplier agreements must include: (1) Supplier evaluation and selection criteria based on ability to meet requirements, (2) Defined product specifications with acceptance criteria, (3) Quality data review requirements (Certificates of Conformance), (4) Receiving inspection and testing procedures, (5) Supplier monitoring and re-evaluation procedures, and (6) Documented assessment and approval of suppliers. FDA expects written supplier agreements demonstrating these controls during inspections.

Design transfer agreements under QSR 820.30 should specify: (1) Design History File (DHF) ownership and maintenance responsibilities, (2) Device Master Record (DMR) transfer and approval procedures, (3) Design verification and validation completion criteria, (4) Production process validation requirements, (5) Design change control procedures, (6) Risk management file maintenance per ISO 14971, and (7) Technical file completion for regulatory submissions. Clear allocation prevents gaps in design control documentation that could delay product launches or cause FDA observations during design control inspections.

QSR Section 820.65 requires device traceability to facilitate corrections and removals. Contracts must mandate: (1) Unique lot or serial number assignment for components and finished devices, (2) Device History Record (DHR) maintenance linking materials to finished devices, (3) Certificate of Conformance or Certificate of Analysis for each lot, (4) Component supplier lot traceability enabling upstream investigations, (5) Manufacturing date, lot numbers, and expiration dates where applicable, and (6) Record retention for minimum of device lifetime plus regulatory retention period. Traceability is essential for targeted recalls and FDA MDR investigations.

QSR 820.198 and 21 CFR Part 803 require formal complaint handling and adverse event reporting. Contracts should specify: (1) Contract manufacturer obligation to forward all complaints to OEM within 24-48 hours, (2) Complaint investigation responsibilities and timelines, (3) MDR reportable event notification procedures, (4) Death, serious injury, and malfunction reporting timelines (5 day and 30 day reports), (5) CAPA initiation for complaint trends, (6) Complaint file documentation and retention, and (7) Regulatory authority inspection cooperation. OEMs remain ultimately responsible for MDR reporting even with outsourced manufacturing.

Justee AI is purpose-built for medical device manufacturing contract review, with a regulatory checklist trained on FDA 21 CFR Part 820 - Quality System Regulation for Medical Devices and adjacent rules. Generic AI tools surface obvious issues like missing signatures or vague terms; Justee AI flags industry-specific compliance gaps — risk allocation, regulatory responsibility, audit and inspection rights, and indemnification language calibrated to medical device manufacturing sector exposure. Every review is fast, secure, and produces a redlined contract with a plain-English explanation of why each clause matters.

Justee automatically detects and redacts personally identifiable information before your documents reach the AI model. Protected types include:

Personal data:
  • Names, email addresses, and phone numbers
  • Social Security numbers and tax identifiers (ITIN)
  • Physical addresses and dates of birth
  • Credit card and bank account numbers
  • Driver's license and passport numbers
  • Medical provider identifiers (NPI) and case numbers
Corporate and business data:
  • Company and organization names
  • Business addresses and geographic locations
  • SWIFT/BIC codes, IBAN numbers, and bank routing numbers
  • Business license numbers and attorney bar IDs
  • Corporate tax identifiers (EIN)
Our system achieves 100% detection of standard PII types and approximately 97% overall coverage. Certain rare identifiers — such as cryptocurrency wallet addresses and MAC addresses — may not be detected automatically. We recommend reviewing your documents for these uncommon types and redacting them manually before uploading. See our Privacy Policy and Terms of Use for details and limitations.

Ready to Review Your Contract?

Upload your contract above to get started. No sign-up required.

Need more reviews? Create a free account

Last updated: May 13, 2026

Privacy

Follow us

LinkedIn

logo

© 2026 Justee. All rights reserved.